Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognosis in ulcerative colitis.

O Broström1

  • 1Karolinska Institute, Stockholm, Sweden.

The Medical Clinics of North America
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

The prognosis for ulcerative colitis has improved, with most patients living normal lives. However, excess mortality risks persist, particularly early after diagnosis and with severe disease, necessitating ongoing research into cancer surveillance and treatment advancements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Family history as a risk factor for colorectal cancer in inflammatory bowel disease.

Gastroenterology·2001
Same author

Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.

Lancet (London, England)·2001
Same author

[Learning among medical students. Teachers' commitment a decisive factor].

Lakartidningen·2000
Same author

Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis.

Alimentary pharmacology & therapeutics·2000
Same author

Increased risk of cancer in ulcerative colitis: a population-based cohort study.

The American journal of gastroenterology·1999
Same author

Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy.

Gastroenterology·1998
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Clinical Medicine
  • Epidemiology

Background:

  • Ulcerative colitis (UC) prognosis has improved over time, yet excess mortality remains a concern.
  • Risk factors for mortality include severe attacks, extensive colitis, and older age at diagnosis.

Purpose of the Study:

  • To analyze the overall prognosis and mortality trends in ulcerative colitis patients.
  • To identify factors influencing disease course and outcomes.
  • To evaluate the impact of medical and surgical treatments on prognosis.

Main Methods:

  • Review of patient populations with ulcerative colitis.
  • Analysis of mortality patterns and causes of death.
  • Assessment of disease progression, complications, and treatment effects.

Related Experiment Videos

Main Results:

  • Majority of patients experience inactive or intermittent disease, with improved overall prognosis.
  • Excess mortality is highest in the initial years post-diagnosis and with disease severity.
  • Colorectal cancer and complications contribute significantly to UC-related deaths, though incidence may be decreasing.

Conclusions:

  • While prognosis has improved, particularly with advancements in surgical and medical treatments, vigilance for complications and mortality risks is essential.
  • Further research into cancer surveillance and prophylactic colectomy may further reduce mortality.
  • Most patients achieve a normal life with full working capacity, adapting well to treatment and surgery.